JEFFREY WEISS, MD

5800 COLONIAL DR STE 300, MARGATE, FL, 33063

Ophthalmology, Regenerative Medicine

Personal Statement

Dr. Jeffrey N. Weiss is President of The American College of Regenerative Medicine and performed the first retinal stem cell surgery in the world in 2010. He is the Principal Investigator of The Stem Cell Ophthalmology Treatment Studies I/II — the largest retinal and optic nerve stem cell studies in the world — as well as The Neurologic Stem Cell Treatment Study, The Stem Cell Spinal Cord Injury Exoskeleton and Virtual Reality Treatment Study, and The Alzheimer's, Cognitive Impairment and Autism Treatment Study. All studies are IRB-approved, registered with NIH, and listed on ClinicalTrials.gov. Dr. Weiss is the former Chief of Retinal Surgery at the Joslin Diabetes Center in Boston, Faculty of Harvard Medical School, and Visiting Scientist at MIT. He is the author of more than 100 publications including 25 books, and holds more than 20 U.S. and foreign patents.
Sourced from Advanced Cellular Regeneration Center. Claim this profile to edit.

Services

Regenerative Medicine
Stem Cell Therapy
Bone Marrow Derived Stem Cells
Retinal Stem Cell Surgery
Age-Related Macular Degeneration (AMD)
Macular Degeneration
Stargardt Disease
Retinitis Pigmentosa
Optic Atrophy
Optic Neuropathy (NAION)
Leber Hereditary Optic Neuropathy (LHON)
Glaucoma
Retinal Disease
Retinopathy
Low Vision
Hyperbaric Oxygen Therapy
Alzheimer's Disease
Parkinson's Disease
ALS
Stroke
Traumatic Brain Injury
Dementia
Cognitive Impairment

Education & Training

Medical School (Summa Cum Laude, age 23); B.S. Electrical Engineering, Magna Cum Laude with distinction; Former Faculty, Harvard Medical School; Former Chief of Retinal Surgery, Joslin Diabetes Center, Boston; Former Visiting Scientist, Massachusetts Institute of Technology.